RxDoctor Payments Data

Lindsay Burroughs, APRN

Psychiatric/Mental Health · Prestonsburg, KYNPI 1093321770

Payments from drug & device makers

$2,062in general payments, 2019–2025

Across 123 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$422
  • Otsuka America Pharmaceutical, Inc.$313
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$235
  • AbbVie$226
  • Neurocrine Biosciences, Inc.$219
  • Alkermes, Inc.$110
  • plus $536 from 12 others

What the payments were for

  • Food & beverage$2,062100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,062 in reported general payments places this provider in the 70th percentile of 946 psychiatric/mental health providers in Kentucky.

See all psychiatric/mental health providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,457
Medicare patients
14
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate18$60,667
LybalviOlanzapine/Samidorphan Malate21$31,606
NuedextaDextromethorphan Hbr/Quinidine11$16,786
RexultiBrexpiprazole11$15,925
AuvelityDextromethorphan Hbr/Bupropion12$13,100
Aripiprazole16$1,243
Trazodone Hcl86$769
Olanzapine31$425
Hydroxyzine Hcl23$339
Venlafaxine Hcl ErVenlafaxine Hcl43$334
Risperidone15$282
Sertraline Hcl32$202
Quetiapine Fumarate23$194
Oxcarbazepine14$152
Hydroxyzine Pamoate11$126

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$41$60,66718 claims
Alkermes, Inc.Lybalvi$110$31,60621 claims
Avanir Pharmaceuticals, Inc.Nuedexta$28$16,78611 claims
Otsuka America Pharmaceutical, Inc.Rexulti$313$15,92511 claims
Axsome Therapeutics, Inc.Auvelity$78$13,10012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 946 psychiatric/mental health providers in Kentucky.

Other psychiatric/mental health in Prestonsburg

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →